Skip to main content

Find Clinical Trials

Home
Conditions
Liver Cirrhosis

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

163 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Completed

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

NCT00827723

Conditions: Adenocarcinoma, Alcohol-Induced Disorders, Alcohol-Related Disorders, +21 more
Locations: Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland

View Trial Details

Completed

Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine

NCT03489889

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, Brazil

View Trial Details

Completed

Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis

NCT02659696

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: Teikyo University School of Medicine Tokyo, Please Select, Japan

View Trial Details

Completed

Use of Fenofibrate for Primary Biliary Cirrhosis

NCT00575042

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: University of Florida Gainesville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

NCT01899703

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +13 more
Locations: GSK Investigational Site Birmingham, West Midlands, United Kingdom

GSK Investigational Site Cambridge, United Kingdom

GSK Investigational Site Newcastle upon Tyne, United Kingdom

View Trial Details

Completed

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

NCT00364819

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Completed

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

NCT00004842

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +13 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis

NCT00805805

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis

NCT02557360

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: Wunsch Szczecin, Poland

Milkiewicz Warsaw, Poland

View Trial Details

Completed

Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

NCT02135536

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: NGM Clinical Study Site 103 Phoenix, Arizona, United States

NGM Clinical Study Site 108 Coronado, California, United States

NGM Clinical Study Site 101 Detroit, Michigan, United States

NGM Clinical Study Site 105 Durham, North Carolina, United States

View all 17 locations

View Trial Details